Avalo Therapeutics shares are trading higher on continued upward momentum after the company agreed to divest AVTX-800 series.
Portfolio Pulse from Benzinga Newsdesk
Avalo Therapeutics' shares are experiencing an upward trend following the company's decision to divest the AVTX-800 series.
September 13, 2023 | 3:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics' decision to divest the AVTX-800 series has led to an increase in the company's share price.
The decision to divest the AVTX-800 series is seen as a positive move by the market, leading to increased demand for Avalo Therapeutics' shares and thus driving up the price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100